{"id":"W4379332790","doi":"10.1200/jco.2023.41.16_suppl.tps4206","title":"STAR-221: A randomized, open-label, multicenter, phase 3 trial of domvanalimab, zimberelimab, and chemotherapy versus nivolumab and chemotherapy in previously untreated, locally advanced, unresectable or metastatic gastric, gastroesophageal junction, and esophageal adenocarcinoma.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; FOLFOX; Internal medicine; Oncology; Oxaliplatin; Chemotherapy; Gastroenterology; Cancer; Immunotherapy; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002401496,0.002074518,0.002747531,0.0004301198,0.0004585978,0.001725706,0.001248161,0.001764129,0.006567792],"category_scores_gemma":[0.001391697,0.0008075371,0.002173609,0.0004354863,0.001481172,0.001493265,0.0006333502,0.004192567,0.001486722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001054407,"about_ca_system_score_gemma":0.001783491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000878725,"about_ca_topic_score_gemma":0.002376632,"domain_scores_codex":[0.9993013,0.0003944902,0.00002704599,0.0001093016,0.00004410231,0.0001237676],"domain_scores_gemma":[0.9990585,0.0001779832,0.0001912561,0.00006951555,0.0000523128,0.0004504004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9701927,0.01158962,0.0005938441,0.0004150997,0.0007341193,0.00004063567,0.00005780634,0.000487934,0.002772722,0.0001585522,0.001310395,0.01164664],"study_design_scores_gemma":[0.9172752,0.0796523,0.00104043,0.00001455348,0.0002652776,0.00004942913,0.00002430231,0.0005314877,0.0003375749,0.0001796963,0.000615994,0.00001380769],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863814,0.002843396,0.0007485605,0.001037019,0.0006540845,0.004464531,0.00147091,0.000195626,0.002204473],"genre_scores_gemma":[0.9790415,0.002447498,0.002223788,0.002049622,0.0005312039,0.006211653,0.002947138,0.00005795668,0.004489784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006567792,"threshold_uncertainty_score":0.02197152,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1123804602371185,"score_gpt":0.4602107707478902,"score_spread":0.3478303105107716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}